Form 4: Cohen & Steers Executive Acquires Dividend Equivalent Restricted Stock Units

Sentiment:

SEC Form 4 Filing


Francis C. Poli, an executive at Cohen & Steers, acquired 137 dividend equivalent restricted stock units.

Summary

  • Francis C. Poli, who is the General Counsel, Secretary, and Executive Vice President at Cohen & Steers, Inc., acquired 137 shares of common stock.
  • These shares were acquired as dividend equivalent restricted stock units.
  • The acquisition is related to the company's fourth quarter 2024 dividend.
  • The units accrued to Poli on unvested restricted stock units granted in January 2021, January 2022, January 2023 and January 2024.
  • The transaction occurred on December 2, 2024.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction related to executive compensation, which is generally neutral to positive. It indicates alignment of executive interests with shareholder returns.

Positives

  • The acquisition of dividend equivalent restricted stock units indicates continued alignment of executive interests with shareholder returns.

Industry Context

This is a routine filing related to executive compensation and is common in the financial services industry.

Comparison to Industry Standards

  • Many financial firms use restricted stock units and dividend equivalents as part of their executive compensation packages.
  • The practice of granting dividend equivalents on unvested shares is a common method to ensure executives are not disadvantaged by the vesting schedule.

Stakeholder Impact

  • The transaction has a minor positive impact on shareholders as it aligns executive compensation with company performance and dividends.

Key Dates

DateDescription
12/02/2024Date of the transaction where Francis C. Poli acquired dividend equivalent restricted stock units.
12/03/2024Date the Form 4 was signed by Brian W. Heller, Attorney-in-Fact.

Keywords

dividend equivalent restricted stock units, insider trading, executive compensation, Form 4, Cohen & Steers, CNS

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.